PHYLLIS DUDA: Open Payments
NPI 1235164583 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,713 in 22 payments from 5 companies in 2025. Trend: 2023 $8,834 · 2024 $13,835 · 2025 $12,713
Consulting: $7,875Travel & lodging: $3,176Speaker / faculty: $1,511Food & beverage: $125Education: $26
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $12,619 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| ARRAY BIOPHARMA INC | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: IBRANCE, INLYTA, PLUVICTO, LYNPARZA, PADCEV, BRAFTOVI, VENCLEXTA.
Industry payments across NJ — which companies pay providers there.
